Anxo Río-Vilariño (Anxo Rio-Vilariño)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Venues

British journal of cancer

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer 130 (8) (2024)
Anxo Río-Vilariño, Jesús García-Foncillas, Arancha Cebrián
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer. British journal of cancer 131 (3) (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer 130 (8) (2024)
Anxo Río-Vilariño, Jesús García-Foncillas, Arancha Cebrián
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer. British journal of cancer 131 (3) (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer 130 (8) (2024)
Anxo Río-Vilariño, Jesús García-Foncillas, Arancha Cebrián
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer. British journal of cancer (2024)
Anxo Río-Vilariño, Jesús García-Foncillas, Arancha Cebrián
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer. British journal of cancer 131 (3) (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer 130 (8) (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer 130 (8) (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer (2024)
Anxo Río-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British journal of cancer 130 (8) (2024)
Anxo Río-Vilariño, Laura Del Puerto-Nevado, Jesús García-Foncillas, Arancha Cebrián
Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance. Cancers 13 (15) (2021)

Anxo Río-Vilariño.css-eqlu8i{font-size:small;padding-left:4px;} (Anxo Rio-Vilariño)

Publication Activity (10 Years)

Top Topics

Top Venues

Anxo Río-Vilariño (Anxo Rio-Vilariño)